Trials / Completed
CompletedNCT03745313
Edwards CLASP TR EFS
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation
Detailed description
The study is a multi-center, prospective, single-arm, and non-randomized study designed to evaluate the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Edwards PASCAL Transcatheter Valve Repair System | Repair of the tricuspid valve through a transcatheter approach |
Timeline
- Start date
- 2019-02-05
- Primary completion
- 2021-05-11
- Completion
- 2025-05-13
- First posted
- 2018-11-19
- Last updated
- 2025-09-29
- Results posted
- 2024-10-09
Locations
15 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03745313. Inclusion in this directory is not an endorsement.